3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Stomach Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Hand-Foot Syndrome
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Bile Duct Neoplasms
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
Cisplatin
38
Fluorouracil
37
Radiotherapy
33
Oxaliplatin
23
Paclitaxel
20
Irinotecan
18
Leucovorin
17
Docetaxel
17
Capecitabine
10
Neoadjuvant Therapy
9
Surgical Procedures, Operative
8
Cetuximab
8
Chemotherapy, Adjuvant
7
Radiation
6
Carboplatin
6
Immunohistochemistry
5
Erlotinib Hydrochloride
5
Biopsy
5
Magnetic Resonance Spectroscopy
4
Gene Expression Profiling
4
Folfox protocol
4
Epirubicin
4
Drug Therapy
4
pembrolizumab
3
Trastuzumab
3
Microarray Analysis
3
Gefitinib
3
Fluorodeoxyglucose F18
3
Endoscopy, Digestive System
3
ixabepilone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adenocarcinoma Of Esophagus
×
tegafur-gimeracil-oteracil
×
Clear all
NCT02128243
2021-03-26
MATEO
AIO-Studien-gGmbH
Phase 2
Completed
242 enrolled